Arrowhead Pharmaceuticals, Inc.

ARWR · Healthcare

$82.74

Markedsværdi: 11.69B USDUdbytteafkast: —
AdvancedEr det et godt tidspunkt at købe Arrowhead Pharmaceuticals, Inc.? Spørg Copenvest AIFå et Advanced AI-bud på timing, risiko og hvad tracked investorer gør.Spørg Copenvest AI

Indlæser diagram…

Nyheder

Seneste overskrifter for denne aktie

Insider Monkey4. sep. 2026, 16.15

Arrowhead (ARWR) Reported a 78% Lower Pancreatitis Event Rate With Plozasiran. Does the Absolute Benefit Support a Broader Label?

Barrons.com4. sep. 2026, 16.13

This Biotech Wins a Big FDA Approval. Why Wall Street Is Shrugging.

Business Wire3. sep. 2026, 11.30

Arrowhead Pharmaceuticals to Participate in Upcoming September 2026 Investor Conferences

Simply Wall St.1. sep. 2026, 11.09

Is Arrowhead Pharmaceuticals (ARWR) Undervalued As SHASTA 3 And SHASTA 4 Data Impress?